BIO International Convention 2026
WATCH THE LATEST FROM BIO 2026
Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
Latest News
BIO 2026: 340B faces growing calls for transparency, patient-focused reform
Experts at the BIO International Convention examine the growth of the 340B drug pricing program, duplicate discounts, patient access, and...
BIO 2026: ‘I am alive today because of biotech’
From sickle cell disease to multiple sclerosis and childhood leukemia, patients and advocates reflected on becoming pioneers in therapies that...
BIO 2026: Biotech threatened by pressures on patent protection
At a time when U.S. biotech leadership is being challenged, the patent system that enables life-saving innovations is beset by...
BIO 2026: American biotech leadership protects patients and national security
Industry and government leaders at BIO 2026 said stronger biotechnology policy, regulatory modernization, and public-private partnerships are essential to maintaining...
BIO 2026: As capital returns, focus on quality over quantity
The new BIO-Norstella State of Emerging Biotech report finds venture capital has returned, pipelines are becoming more efficient, and emerging...
BIO 2026: Biotech dealmakers navigate uncertainty, pursue opportunities
Executives at BIO 2026 said biotech partnerships, licensing deals, and acquisitions remain strong as companies adapt their business development strategies...